Terminated PHASE2 INTERVENTIONAL NCT00145873

Nesiritide in Chronic Heart Failure

Continuous Infusion Nesiritide in Chronic Heart Failure-University of Chicago (CINCH-UC)

Sponsor: Scios, Inc.

Interventions nesiritide, continuous infusion

Updated 6 times since 2017 Last updated: Oct 7, 2013 Started: Aug 31, 2003 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to complete study

Other terminated trials from Scios, Inc.

Cardiac Transplantation · Phase PHASE2 · Oct 2007

More terminations from Scios, Inc.

Other Heart Failure trials with similar outcome

Browse all Heart Failure trials

A PHASE2 clinical study on Heart Failure, this trial is terminated or withdrawn. The trial is conducted by Scios, Inc. and has accumulated 6 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scios, Inc.
University of Chicago

Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States